Cargando…

Current Understanding of Lifestyle and Environmental Factors and Risk of Non-Hodgkin Lymphoma: An Epidemiological Update

The incidence rates of non-Hodgkin lymphoma (NHL) have steadily increased over the last several decades in the United States, and the temporal trends in incidence can only be partially explained by the HIV epidemic. In 1992, an international workshop sponsored by the United States National Cancer In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bassig, Bryan A., Lan, Qing, Rothman, Nathaniel, Zhang, Yawei, Zheng, Tongzhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447374/ https://www.ncbi.nlm.nih.gov/pubmed/23008714 http://dx.doi.org/10.1155/2012/978930

Ejemplares similares

Identification of Predictive Pathways for Non-Hodgkin Lymphoma Prognosis
por: Han, Xuesong, et al.
Publicado: (2010)

Occupational Exposure to Benzene and Non-Hodgkin Lymphoma in a Population-Based Cohort: The Shanghai Women’s Health Study
por: Bassig, Bryan A., et al.
Publicado: (2015)

Polymorphisms in Th1/Th2 Cytokine Genes, Hormone Replacement Therapy, and Risk of Non-Hodgkin Lymphoma
por: Zhu, Gongjian, et al.
Publicado: (2011)

Mitochondrial DNA Fragmentation and Risk of Non-Hodgkin Lymphoma
por: Hosgood, H. Dean, et al.
Publicado: (2023)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

Common Gene Variants in the Tumor Necrosis Factor (TNF) and TNF Receptor Superfamilies and NF-kB Transcription Factors and Non-Hodgkin Lymphoma Risk
por: Wang, Sophia S., et al.
Publicado: (2009)

Current advances in Hodgkin’s lymphoma
por: Vadakara, Joseph, et al.
Publicado: (2019)

An Update on the Pathology and Molecular Features of Hodgkin Lymphoma
por: Satou, Akira, et al.
Publicado: (2022)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
por: Biasoli, Irene, et al.
Publicado: (2023)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
por: Voorhees, Timothy J, et al.
Publicado: (2020)

An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
por: Ferrarini, Isacco, et al.
Publicado: (2023)

Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium
por: ‘t Mannetje, Andrea, et al.
Publicado: (2015)

Current approaches to the treatment of non-Hodgkin's lymphoma
por: Gisselbrecht, Christian
Publicado: (2011)

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
por: Pytlik, Robert, et al.
Publicado: (2020)

Current directions in the treatment of classical Hodgkin lymphoma
por: Keller, Frank G., et al.
Publicado: (2023)

Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
por: Salati, Massimiliano, et al.
Publicado: (2014)

Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
por: Hernandez-Ruiz, Eleazar, et al.
Publicado: (2021)

Clinical and Epidemiological Profile of Elderly Hodgkin’s Lymphoma in India
por: Sharma, Manish, et al.
Publicado: (2022)

Clinical, Molecular, and Environmental Risk Factors for Hodgkin Lymphoma
por: Maggioncalda, Alison, et al.
Publicado: (2011)

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
por: Fedele, Roberta, et al.
Publicado: (2015)

Updates in the Role of Checkpoint Inhibitor Immunotherapy in Classical Hodgkin’s Lymphoma
por: Nakhoda, Shazia, et al.
Publicado: (2022)

Genetically Determined Height and Risk of Non-hodgkin Lymphoma
por: Moore, Amy, et al.
Publicado: (2020)

Current Status of the Epidemiologic Evidence Linking Polychlorinated Biphenyls and Non-Hodgkin Lymphoma, and the Role of Immune Dysregulation
por: Kramer, Shira, et al.
Publicado: (2012)

Progress in understanding the biology of nodular lymphocyte-predominant Hodgkin lymphoma
por: Straus, David J.
Publicado: (2021)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
por: Poggio, Teresa, et al.
Publicado: (2018)

Advances in the treatment of Hodgkin lymphoma: Current and future approaches
por: Ullah, Fauzia, et al.
Publicado: (2023)

Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib
por: Brander, Danielle M, et al.
Publicado: (2012)

Update on Salvage Options in Relapsed/Refractory Hodgkin Lymphoma after Autotransplant
por: Iqbal, Nida, et al.
Publicado: (2014)

Exposure to glyphosate and risk of non-hodgkin lymphoma: an updated meta-analysis
por: Boffetta, Paolo, et al.
Publicado: (2021)

Methodologic frontiers in environmental epidemiology.
por: Rothman, K J
Publicado: (1993)

Herbicide use in farming and other jobs in relation to non-Hodgkin’s lymphoma (NHL) risk
por: De Roos, Anneclaire J, et al.
Publicado: (2022)

Clinical and epidemiologic characteristics of non Hodgkin’s lymphoma in Bedouins in the south of Israel
por: Levi, Itai, et al.
Publicado: (2013)

PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA.
por: Ben Sghaier, R., et al.
Publicado: (2022)

Vitamin D status and risk of non-Hodgkin lymphoma: An updated meta-analysis
por: Park, Hye Yin, et al.
Publicado: (2019)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

An update on current understanding of the epidemiology and management of the re-emerging endemic Lassa fever outbreaks
por: Malik, Sumira, et al.
Publicado: (2023)

A Case–Control Study of Occupational Exposure to Trichloroethylene and Non-Hodgkin Lymphoma
por: Purdue, Mark P., et al.
Publicado: (2011)

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes
por: Moore, Amy, et al.
Publicado: (2021)

Hodgkin: Update 2018
por: Hutchings, Martin
Publicado: (2018)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_rrajqngcoi2o4ne6tnccik9d25